Phase 1/2a study with lead Radio-DARPin MP0712 initiated; first patient dosing expected Q1 2026, initial data anticipated in 2026Full imaging and dosimetry data from MP0712 compassionate care program ...

Cancer Research Horizons (CRH) is on the lookout for potentially transformative oncology drugs that could benefit from its expertise. CRH, which is the innovation arm of the charity Cancer Research UK ...

Can-Fite’s upfront and royalties on sales upon regulatory approval of Piclidenoson for veterinary use, is projected to be $325 million in the aggregate over the next decade assuming a 2029 launch ...

With the rise of biologics, precision medicine and AI-driven drug discovery, clinical research has entered a new and complex ...

Walgreens Boots Alliance WBA recently announced a strategic partnership with BARDA (Biomedical Advanced Research and Development Authority) as part of the D-COHRe (Decentralized Clinical Operations ...

Data sharing technology company Datavant has expanded its collaboration with pharmaceutical company Boehringer Ingelheim to support Boehringer's real-world evidence initiatives. The extended ...

Healthcare data analytics company Komodo Health is partnering with Anervea.ai, an AI-native life sciences technology company, to develop and deploy an AI-powered suite of applications on Komodo's ...

Bari Kowal, Senior Vice President, Development Operations & Portfolio Management at Regeneron Clinical trial innovation is a hot topic, but it’s not a new one. The first fully virtual randomized trial ...

As advancements in medical science progress, clinical research and development (R&D) are subject to more sophisticated and complex study designs and protocols that require precise global coordination ...

Illumina Taiwan Biotechnology Co., Ltd., and Precision Medicine Asia, Limited (PREMIA), a leading Asian cancer ...